ASCL1 and major depressive disorder: The alterations in Sox2 and MASH1 expression may have functional implications; such changes can potentially influence neural plasticity, neurogenesis, and overall brain function (7, 25), which, in turn, might affect the clinical manifestations of MDD and BPD.